FDA Works To Stay Focused As Its Heads Spin; Deputies In Spotlight
This article was originally published in The Tan Sheet
Executive Summary
A key challenge for FDA following the resignation of Commissioner Lester Crawford will be overcoming the impression that being without a permanent leader yet again will result in a period of stasis at the agency